| Autor: |
Piemonte, F, Carraturo, A, Damiano, S, De Angelis, A, Forte, R, Leccia, A, Lirato, C, Molaro, M, Penna, G, Petitto, M, Piemonte, M, Puzio, E |
| Zdroj: |
European Heart Journal Supplements: Journal of the European Society of Cardiology; May 2023, Vol. 25 Issue: 1, Number 1 Supplement 4 pD64-D65, 2p |
| Abstrakt: |
For about 2 months (from 13 January to 15 March 2022) our CICU–Cardiology department (spoke for the AMI network) of the "San Giovanni di Dio" Hospital of Frattamaggiore (Napoli) has assumed the role of Covid–CICU for ASL Napoli 2 Nord. We analyzed the data regarding patients hospitalized for acute myocardial infarction in our department from January to August, selected on the basis of the presence of SARS–COV2 infection at admission, and we noted some substantial differences between the two populations, although in the small sample examined. 15 of the 44 patients hospitalized with Covid (34%) were discharged with a diagnosis of acute myocardial infarction, while among non–Covid patients 46.4% had acute myocardial infarction. The average age and days of hospitalization were higher in Covid patients (70 vs 67 years and 8.9 vs 6 days), and Covid patients with myocardial infarction and heart failure were 50% vs 24.7% of non–Covid patients. Diabetes was present in 31.5% of Covid patients and 15.7% in non–Covid. The number of STEMIs was higher in the Covids (53.3% vs 15.7% of the non–Covids), probably because being CICU–COVID we also accepted patients with STEMI who otherwise would have been hospitalized in the CICU HUB. Despite the difficulties in managing acute coronary syndromes in Covid patients, 60% of all Covid patients hospitalized for infarction underwent a haemodynamic study (73% in non–Covid patients) and primary PTCA was guaranteed for 87.5% of Covid patients with STEMI in a reasonable time in that context (< 9 hours from admission to hospital). However, in the face of this considerable organizational effort, the 6–month and intra–hospital mortality in Covid patients hospitalized for infarction was 31.5% and 12.5%, much higher than that of non–Covid patients (2.2% and 1.1% respectively ). The STEMi data from COVID patients is not comforting either: in fact, 25% of them died within 6 months and 12.5% in hospital, despite almost all of them were treated with primary PTCA, although not in the first 3 hours. But the mortality of the Covid patients in our department with a prevalent respiratory commitment is even higher than that of the Covid patients with AMI, reaching 40% at 6 months. In the light of our limited experience, we can hypothesize that the therapeutic protocols used in heart attacks, despite the inevitable delays due to Covid and although they are not as effective as in non–Covid patients, nevertheless can have impact on the prognosis. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
